Elevated plasma levels of CXCL16 in severe COVID-19 patients
View ORCID ProfileSandra P. Smieszek, Vasilios M. Polymeropoulos, Christos M. Polymeropoulos, Bartlomiej P. Przychodzen, Gunther Birznieks, Mihael H. Polymeropoulos
doi: https://doi.org/10.1101/2021.09.07.21263222
Sandra P. Smieszek
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Vasilios M. Polymeropoulos
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Christos M. Polymeropoulos
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Bartlomiej P. Przychodzen
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Gunther Birznieks
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Mihael H. Polymeropoulos
1Vanda Pharmaceuticals Inc., Washington, DC, USA
Data Availability
Data available upon request
Posted September 12, 2021.
Elevated plasma levels of CXCL16 in severe COVID-19 patients
Sandra P. Smieszek, Vasilios M. Polymeropoulos, Christos M. Polymeropoulos, Bartlomiej P. Przychodzen, Gunther Birznieks, Mihael H. Polymeropoulos
medRxiv 2021.09.07.21263222; doi: https://doi.org/10.1101/2021.09.07.21263222
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (3002)
- Dermatology (256)
- Emergency Medicine (449)
- Epidemiology (12898)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4698)
- Geriatric Medicine (432)
- Health Economics (742)
- Health Informatics (2986)
- Health Policy (1081)
- Hematology (399)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4486)
- Nursing (239)
- Nutrition (657)
- Oncology (2329)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (290)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (509)
- Public and Global Health (7072)
- Radiology and Imaging (1570)
- Respiratory Medicine (933)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (497)
- Toxicology (62)
- Transplantation (214)
- Urology (187)